Rani Therapeutics Holdings Inc (RANI)

Dec 20, 2024

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $11.71 Average PT from Brokerages - MarketBeat

Dec 20, 2024

Dec 19, 2024

Rani Therapeutics stock hits 52-week low at $1.32 - Investing.com

Dec 19, 2024

Dec 16, 2024

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Insider Kate Mckinley Acquires 17,960 Shares - MarketBeat

Dec 16, 2024

Dec 11, 2024

Rani Therapeutics stock hits 52-week low at $1.85 By Investing.com - Investing.com Nigeria

Dec 11, 2024

Dec 11, 2024

Rani Therapeutics stock hits 52-week low at $1.85 - Investing.com India

Dec 11, 2024

Dec 03, 2024

Rani Therapeutics stock hits 52-week low at $1.94 By Investing.com - Investing.com Nigeria

Dec 03, 2024

Dec 02, 2024

Rani Therapeutics stock hits 52-week low at $1.94 - Investing.com India

Dec 02, 2024

Nov 28, 2024

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives $11.71 Average Target Price from Analysts - Defense World

Nov 28, 2024

Nov 25, 2024

Brokerages Set Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Price Target at $11.71 - MarketBeat

Nov 25, 2024

Nov 25, 2024

What is Zacks Small Cap’s Forecast for RANI FY2024 Earnings? - Defense World

Nov 25, 2024

Nov 25, 2024

What is Zacks Small Cap's Forecast for RANI FY2024 Earnings? - MarketBeat

Nov 25, 2024

Nov 20, 2024

RANI: Third Quarter Update - MSN

Nov 20, 2024

Nov 19, 2024

Rani Therapeutics' (RANI) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat

Nov 19, 2024

Nov 18, 2024

Rani Therapeutics Advances in Biotherapeutics Market - TipRanks

Nov 18, 2024

Nov 15, 2024

Rani Therapeutics Holdings Inc (RANI) Quarterly 10-Q Report - Quartzy

Nov 15, 2024

Nov 15, 2024

ARMISTICE CAPITAL, LLC Acquires New Stake in Rani Therapeutics H - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update - The Manila Times

Nov 14, 2024

Nov 14, 2024

Rani Therapeutics Slashes Q3 Loss by 31%, Secures $20M Funding for GLP-1 Development | RANI Stock News - StockTitan

Nov 14, 2024

Nov 07, 2024

Rani Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times

Nov 07, 2024

Nov 03, 2024

Brokerages Set Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) PT at $11.71 - Defense World

Nov 03, 2024

Oct 31, 2024

Analysts Set Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Target Price at $11.71 - MarketBeat

Oct 31, 2024

Oct 25, 2024

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Sees Significant Growth in Short Interest - MarketBeat

Oct 25, 2024

Oct 23, 2024

Allied Gaming & Entertainment And 2 Other US Penny Stocks To Watch - Simply Wall St

Oct 23, 2024

Oct 22, 2024

RANI: New Triagonist Data in Weight Loss - Zacks Small Cap Research

Oct 22, 2024

Oct 19, 2024

Rani Therapeutics shares hold buy rating on positive preclinical data By Investing.com - Investing.com Australia

Oct 19, 2024

Oct 19, 2024

Rani Therapeutics stock gets positive outlook from H.C. Wainwright after novel obesity candidate progress - Investing.com Australia

Oct 19, 2024

Oct 19, 2024

U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.75% - MSN

Oct 19, 2024

Oct 18, 2024

Rani Therapeutics shares hold buy rating on positive preclinical data - Investing.com

Oct 18, 2024

Oct 18, 2024

Rani Therapeutics (NASDAQ:RANI) Receives "Buy" Rating from HC Wainwright - MarketBeat

Oct 18, 2024

Oct 18, 2024

Rani Therapeutics reports promising obesity treatment delivery By Investing.com - Investing.com South Africa

Oct 18, 2024

Oct 18, 2024

Rani therapeutics sees $10 million in stock sales by major investors By Investing.com - Investing.com

Oct 18, 2024

Oct 17, 2024

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Major Shareholder South Cone Investments Limited Sells 3,829,360 Shares - MarketBeat

Oct 17, 2024

Oct 17, 2024

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.75% - MSN

Oct 17, 2024

Oct 17, 2024

Rani Therapeutics reports promising obesity treatment delivery - Investing.com

Oct 17, 2024

Oct 17, 2024

Rani Therapeutics Announces New Preclinical Pharmacokinetic - GlobeNewswire

Oct 17, 2024

Oct 17, 2024

Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist - The Manila Times

Oct 17, 2024

Oct 17, 2024

Rani Therapeutics (RANI) Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist - StreetInsider.com

Oct 17, 2024

Oct 16, 2024

Rani Therapeutics to sell 3M shares at $3.00 in registered direct offering - MSN

Oct 16, 2024

Oct 16, 2024

Recent Insider Activity Could Benefit Comcast Corp (CMCSA) - Knox Daily

Oct 16, 2024

Oct 16, 2024

Market Momentum: Rani Therapeutics Holdings Inc (RANI) Registers a -33.33 Decrease, Closing at 2.12 - The Dwinnex

Oct 16, 2024

Oct 16, 2024

There is no doubt that Rani Therapeutics Holdings Inc (RANI) ticks all the boxes. - SETE News

Oct 16, 2024

Oct 16, 2024

An Analysis of Avidity Biosciences Inc (RNA)’s Potential Price Growth - Knox Daily

Oct 16, 2024

Oct 16, 2024

Form 424B5 Rani Therapeutics Holdin - StreetInsider.com

Oct 16, 2024